COMMUNIQUÉS West-GlobeNewswire

Top Line Results from Glaucoma Dolomites Phase 2 Trial Show Nicox’s NCX 470 Meets Primary Endpoint and Demonstrates Statistical Superiority vs Latanoprost

02/10/2019 - 07:30

Press Release Top Line Results from Glaucoma Dolomites Phase 2 Trial Show Nicox’s NCX 470 Meets Primary Endpoint and Demonstrates Statistical Superiority vs Latanoprost NCX 470 met the primary endpoint of non- [...]

Nexstim Plc in Technology Licensing Discussions with a Leading California Based Academic Institution

02/10/2019 - 08:00

Company announcement, Helsinki 2 October 2019 at 9.00 AM (EEST) Nexstim Plc in Technology Licensing Discussions with a Leading California Based Academic Institution Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or " [...]

New Data Presented on ASLAN’s varlitinib at ESMO 2019

02/10/2019 - 08:30

SINGAPORE, Oct. 02, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage oncology and immunology focused biopharma company, today announced the presentation of new data from a phase [...]

AgraFlora Organics Reviews Delta Greenhouse Infrastructure Upgrades; Deploys Over C$30,000,000 in PPE Expenditures

02/10/2019 - 09:01

VANCOUVER, British Columbia, Oct. 02, 2019 (GLOBE NEWSWIRE) -- AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) ( CSE: AGRA) (Frankfurt: PU31) (OTCPK: AGFAF ), a growth oriented and diversified [...]

Demant A/S: Change of date of publication of Interim Management Statement

02/10/2019 - 09:53

Company announcement no 2019- 12 2 October 2019 Change of date of publication of Interim Management Statement The date of publication of Demant’s Interim Management Statement has been changed from 7 November to 18 [...]

RavenQuest BioMed to Hold Third Quarter Conference Call

01/10/2019 - 23:56

VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (CSE: RQB OTCQB: RVVQF Frankfurt: 1IT) (the “ Company ” or “ RavenQuest ”), one of Canada’s most innovative cannabis producers, [...]

Jounce Therapeutics to Present Two Posters from the JTX-4014 and Vopratelimab Programs at the Society for Immunotherapy of Cancer’s (SITC) 34th Annual Meeting

02/10/2019 - 00:01

CAMBRIDGE, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]

NextCure to Present Clinical Data from NC318 Phase 1/2 Clinical Trial at 34th Annual Meeting of SITC

02/10/2019 - 00:20

BELTSVILLE, Md., Oct. 01, 2019 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer [...]

BriaCell Therapeutics Corp. to Clarify Record Date

02/10/2019 - 01:00

BERKELEY, Calif. and VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (“BriaCell” or the “Company”) (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]

Information relative au nombre total de droits de vote et d’actions composant le capital social au 30 septembre 2019

01/10/2019 - 18:00

Paris, le 1 er octobre 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de [...]

Information on total number of voting rights and shares composing the share capital as at September 30, 2019

01/10/2019 - 18:00

Paris, October 1 st , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent [...]

SuperSonic Imagine Innovates in Ultrasound with Its New Liver Markers

01/10/2019 - 18:00

A suite of three new tools is available on Aixplorer MACH 30 ultrasound platform AIX-EN-PROVENCE, France, Oct. 01, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814), a company specializing in [...]

Virbac : Déclaration d'actions et de droits de vote 09/2019

01/10/2019 - 18:11

DECLARATION D’ACTIONS ET DE DROITS DE VOTE Informations relatives au nombre total de droits de vote et au nombre d’actions composant le capital (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) [...]

Virbac : Declaration of the number of shares and voting rights 09/2019

01/10/2019 - 18:11

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS Information on the total number of voting rights and of shares representing the share capital (Article 223-16 of the General regulations of the French Financial [...]

Generex Biotechnology Announces Investor Conference Call Scheduled for Tuesday October 15, 2019 at 9:30 AM

01/10/2019 - 18:40

MIRAMAR, Fla., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) (OTCQB:GNBT) today announced that it will hold an investor conference call on Tuesday October 15, 2019 at 9:30 am. [...]

B. Braun Successfully Integrate Smart Pumps with STANLEY Healthcare at Saratoga Hospital

01/10/2019 - 19:48

BETHLEHEM, Pa., Oct. 01, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. (“B.Braun”) announced today the integration and deployment of their Space™ Infusion Pump Systems with STANLEY Healthcare’s software platform, [...]

Theratechnologies annoncera ses résultats du troisième trimestre de 2019

01/10/2019 - 20:14

MONTRÉAL, 01 oct. 2019 (GLOBE NEWSWIRE) -- Theratechnologies inc. («Theratechnologies») (TSX : TH) a annoncé aujourd’hui qu’elle dévoilerait ses résultats financiers mardi le 8 octobre 2019 pour le troisième trimestre [...]

Theratechnologies to Announce Financial Results for Third Quarter 2019

01/10/2019 - 20:14

MONTREAL, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the third quarter ended August 31, 2019, on Tuesday, October [...]

Capital Increase in Genmab as a Result of Employee Warrant Exercise

01/10/2019 - 20:14

Company Announcement Copenhagen, Denmark; October 1, 2019 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 28,719 shares as a consequence of the exercise of employee warrants. The increase is effected [...]